(Q43052323)

13 November 2017

title

Characterization of site-specific O-glycan structures within the mucin-like domain of alpha-dystroglycan from human skeletal muscle (English)

1 reference

13 November 2017

Johanna Nilsson

1

1 reference

13 November 2017

Jonas Nilsson

series ordinal

2

1 reference

13 November 2017

Göran Larson

series ordinal

3

1 reference

13 November 2017

Ammi Grahn

series ordinal

4

1 reference

13 November 2017

publication date

27 May 2010

1 reference

13 November 2017

1 reference

13 November 2017

volume

20

1 reference

13 November 2017

issue

9

1 reference

13 November 2017

page(s)

1160-1169

1 reference

Mutational and functional analysis of Large in a novel CHO glycosylation mutant

13 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWQ082

Multiple cell culture factors can affect the glycosylation of Asn-184 in CHO-produced tissue-type plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWQ082

Dystroglycan: from biosynthesis to pathogenesis of human disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWQ082

LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWQ082

Mutations in the FKRP gene can cause muscle-eye-brain disease and Walker-Warburg syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWQ082

Initiation of mammalian O-mannosylation in vivo is independent of a consensus sequence and controlled by peptide regions within and upstream of the alpha-dystroglycan mucin domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWQ082

Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWQ082

Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve alpha-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of alpha-dystroglycan with laminin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWQ082

Enhanced laminin binding by alpha-dystroglycan after enzymatic deglycosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWQ082

Glycosylation in congenital muscular dystrophies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWQ082

Tissue-specific heterogeneity in alpha-dystroglycan sialoglycosylation. Skeletal muscle alpha-dystroglycan is a latent receptor for Vicia villosa agglutinin b4 masked by sialic acid modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWQ082

Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWQ082

Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWQ082

Human dystroglycan: skeletal muscle cDNA, genomic structure, origin of tissue specific isoforms and chromosomal localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWQ082

Glycosylation of recombinant proteins: problems and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWQ082

Getting the glycosylation right: implications for the biotechnology industry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWQ082

A comparative study of alpha-dystroglycan glycosylation in dystroglycanopathies suggests that the hypoglycosylation of alpha-dystroglycan does not consistently correlate with clinical severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWQ082

Regulation of mammalian protein O-mannosylation: preferential amino acid sequence for O-mannose modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWQ082

Differential Vicia villosa agglutinin reactivity identifies three distinct dystroglycan complexes in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWQ082

Core 1 glycans on alpha-dystroglycan mediate laminin-induced acetylcholine receptor clustering but not laminin binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWQ082

Brain alpha-dystroglycan displays unique glycoepitopes and preferential binding to laminin-10/11

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWQ082

Phenotypic spectrum associated with mutations in the fukutin-related protein gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWQ082

POMT2 mutation in a patient with 'MEB-like' phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWQ082

Spectrum of brain changes in patients with congenital muscular dystrophy and FKRP gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWQ082

Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWQ082

Mouse large can modify complex N- and mucin O-glycans on alpha-dystroglycan to induce laminin binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWQ082

The phenotype of limb-girdle muscular dystrophy type 2I

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWQ082

Structural analysis of sequences O-linked to mannose reveals a novel Lewis X structure in cranin (dystroglycan) purified from sheep brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWQ082

POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWQ082

The expanding phenotype of POMT1 mutations: from Walker-Warburg syndrome to congenital muscular dystrophy, microcephaly, and mental retardation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWQ082

The complexities of dystroglycan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWQ082

Dystroglycan is a binding protein of laminin and merosin in peripheral nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWQ082

O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWQ082

21 January 2018

Identifiers

DOI

10.1093/GLYCOB/CWQ082

1 reference

13 November 2017

1 reference